These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 5563349)
1. An analysis of the University Group Diabetes Study Program: data results and conslusions. Leibel B Can Med Assoc J; 1971 Aug; 105(3):292-4. PubMed ID: 5563349 [No Abstract] [Full Text] [Related]
2. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation]. Pirart J Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448 [No Abstract] [Full Text] [Related]
3. The University Group Diabetes Program. A further statistical analysis of the mortality findings. Cornfield J JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386 [No Abstract] [Full Text] [Related]
4. Clinical biostatistics. 8. An analytic appraisal of the University Group Diabetes Program (UGDP) study. Feinstein AR Clin Pharmacol Ther; 1971; 12(2):167-91. PubMed ID: 4324447 [No Abstract] [Full Text] [Related]
5. The University Group Diabetes Program. A statistician looks at the mortality results. Schor S JAMA; 1971 Sep; 217(12):1671-5. PubMed ID: 4937385 [No Abstract] [Full Text] [Related]
6. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP). Seltzer HS Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722 [No Abstract] [Full Text] [Related]
7. [Statistical data from the diabetic care and control station of the Medical University Clinic in Innsbruck]. Leubner H Wien Klin Wochenschr; 1966 Oct; 78(43):739-41. PubMed ID: 5996748 [No Abstract] [Full Text] [Related]
8. The diabetes supplement of the National Health Survey. McDonald GW J Am Diet Assoc; 1968 Feb; 52(2):118-20. PubMed ID: 5636541 [No Abstract] [Full Text] [Related]
9. [University Group Diabetes Program. The UGDP investigation remains clinically unacceptable]. Aarseth S Tidsskr Nor Laegeforen; 1976 Aug; 96(22):1148. PubMed ID: 951693 [No Abstract] [Full Text] [Related]
11. Status of problem of usage of tolbutamide. Preliminary statements. Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867 [No Abstract] [Full Text] [Related]
12. Why the conclusions of the University Group Diabetes Project are incorrect. Moss JM Proc Annu Meet Med Sect Am Life Insur Assoc; 1975; (3):66-72. PubMed ID: 1233508 [No Abstract] [Full Text] [Related]
13. Avoiding the pitfalls of long-term therapeutic trials: lessons learned from the UGDP study. Seltzer HS J Clin Pharmacol New Drugs; 1972 Oct; 12(10):393-8. PubMed ID: 4627326 [No Abstract] [Full Text] [Related]
14. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures]. Tattersall RB Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219 [No Abstract] [Full Text] [Related]
15. Editorials: Statistical problems in clinical trials: the UGDP study revisited. Schor SS Am J Med; 1973 Dec; 55(6):727-32. PubMed ID: 4584989 [No Abstract] [Full Text] [Related]
16. [Hepatic steatosis in diabetics. The place of dolipol in its treatment]. Journ Annu Diabetol Hotel Dieu; 1968; 9():423-6. PubMed ID: 5748223 [No Abstract] [Full Text] [Related]
17. The diabetes supplement of the National Health Survey. Fuchsberg RR J Am Diet Assoc; 1968 Feb; 52(2):121-4. PubMed ID: 5636542 [No Abstract] [Full Text] [Related]
18. Tolbutamide and diabetes. Can Med Assoc J; 1971 Jun; 104(12):1067. PubMed ID: 5580750 [No Abstract] [Full Text] [Related]
19. [Latent diabetes as a hazard factor in myocardial infarct]. Möller H Z Gesamte Inn Med; 1968 Mar; 23(6):89-90. PubMed ID: 5727300 [No Abstract] [Full Text] [Related]
20. Prevalence, awareness, treatment and control of hypertension and diabetes mellitus among the elderly: the 2004 National Health Examination Survey III, Thailand. Porapakkham Y; Pattaraarchachai J; Aekplakorn W Singapore Med J; 2008 Nov; 49(11):868-73. PubMed ID: 19037551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]